SEARCH

SEARCH BY CITATION

References

  • Almkvist O., Basun H., Wagner S. L., Rowe B. A., Wahlund L. O. and Lannfelt L. (1997) Cerebrospinal fluid levels of α-secretase-cleaved soluble amyloid precursor protein mirror cognition in a Swedish family with Alzheimer disease and a gene mutation. Arch. Neurol. 54, 641644.
  • Anderson J. J., Holtz G., Baskin P. P., Wang R., Mazzarelli L., Wagner S. L. and Menzaghi F. (1999) Reduced cerebrospinal fluid levels of alpha-secretase-cleaved amyloid precursor protein in aged rats: correlation with spatial memory deficits. Neuroscience 93, 14091420.
  • Bliss T., Collingridge G. and Morris R. G. (2007) Synaptic plasticity in the hippocampus, in The Hippocampus Book (Andersen P., Morris R. G., Amaral D. and O’Keefe J., eds), pp. 343474. Oxford University Press, Oxford, New York.
  • Bour A., Little S., Dodart J. C., Kelche C. and Mathis C. (2004) A secreted form of the beta-amyloid precursor protein (sAPP695) improves spatial recognition memory in OF1 mice. Neurobiol. Learn. Mem. 81, 2738.
  • Bozdagi O., Nagy V., Kwei K. T. and Huntley G. W. (2007) In vivo roles for matrix metalloproteinase-9 in mature hippocampal synaptic physiology and plasticity. J. Neurophysiol. 98, 334344.
  • Colciaghi F., Borroni B., Pastorino L., Marcello E., Zimmermann M., Cattabeni F., Padovani A. and Di Luca M. (2002) [alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients. Mol. Med. 8, 6774.
  • Fazeli M. S., Breen K., Errington M. L. and Bliss T. V. (1994) Increase in extracellular NCAM and amyloid precursor protein following induction of long-term potentiation in the dentate gyrus of anaesthetized rats. Neurosci. Lett. 169, 7780.
  • Fisher K. E., Fei Q., Laird E. R., Stock J. L., Allen M. R., Sahagan B. G. and Strick C. A. (2002) Engineering autoactivating forms of matrix metalloproteinase-9 and expression of the active enzyme in cultured cells and transgenic mouse brain. Biochemistry 41, 82898297.
  • Fragkouli A., Tzinia A. K., Charalampopoulos I., Gravanis A. and Tsilibary E. C. (2011) Matrix metalloproteinase-9 participates in NGF-induced α-secretase cleavage of amyloid-β protein precursor in PC12 cells. J. Alzheimers Dis. 24, 705719.
  • Georgopoulos S., McKee A., Kan H. Y. and Zannis V. I. (2002) Generation and characterization of two transgenic mouse lines expressing human ApoE2 in neurons and glial cells. Biochemistry 41, 92939301.
  • Hoey S. E., Williams R. J. and Perkinton M. S. (2009) Synaptic NMDA receptor activation stimulates alpha-secretase amyloid precursor protein processing and inhibits amyloid-beta production. J. Neurosci. 29, 44424460.
  • Ishida A., Furukawa K., Keller J. N. and Mattson M. P. (1997) Secreted form of beta-amyloid precursor protein shifts the frequency dependency for induction of LTD, and enhances LTP in hippocampal slices. Neuroreport 8, 21332137.
  • Lannfelt L., Basun H., Wahlund L. O., Rowe B. A. and Wagner S. L. (1995) Decreased α-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer’s disease. Nat. Med. 1, 829832.
  • Leuner B. and Shors T. J. (2004) New spines, new memories. Mol. Neurobiol. 29, 117130.
  • Matrone C., Di Luzio A., Meli G., D’Aguanno S., Severini C., Ciotti M. T., Cattaneo A. and Calissano P. (2008) Activation of the amyloidogenic route by NGF deprivation induces apoptotic death in PC12 cells. J. Alzheimers Dis. 13, 8196.
  • Meighan S. E., Meighan P. C., Choudhury P., Davis C. J., Olson M. L., Zornes P. A., Wright J. W. and Harding J. W. (2006) Effects of extracellular matrix-degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity. J. Neurochem. 96, 12271241.
  • Meziane H., Dodart J. C., Mathis C., Little S., Clemens J., Paul S. M. and Ungerer A. (1998) Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice. Proc. Natl. Acad. Sci. U S A 95, 1268312688.
  • Michaluk P. and Kaczmarek L. (2007) Matrix metalloproteinase-9 in glutamate-dependent adult brain function and dysfunction. Cell Death Differ. 14, 12551258.
  • Milward E. A., Fitzsimmons C., Szklarczyk A. and Conant K. (2007) The matrix metalloproteinases and CNS plasticity: an overview. J. Neuroimmunol. 187, 919.
  • Mizoguchi H., Ibi D., Takuma K., Toth E., Sato J., Itohara S., Nobeshima T. and Yamada K. (2010) Alterations of emotional and cognitive behaviors in matrix metalloproteinase-2 and -9-deficient mice. Open Behav. Sci. J. 4, 1925.
  • Nagase H. and Woessner J. F. (1999) Matrix metalloproteinases. J. Biol. Chem. 274, 2149121494.
  • Nagy V., Bozdagi O., Matynia A., Balcerzyk M., Okulski P., Dzwonek J., Costa R. M., Silva A. J., Kaczmarek L. and Huntley G. W. (2006) Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. J. Neurosci. 26, 19231934.
  • Nagy V., Bozdagi O. and Huntley G. W. (2007) The extracellular protease matrix metalloproteinase-9 is activated by inhibitory avoidance learning and required for long-term memory. Learn. Mem. 14, 65566564.
  • Okulski P., Jay T. M., Jaworski J., Duniec K., Dzwonek J., Konopacki F. A., Wilczynski G. M., Sánchez-Capelo A., Mallet J. and Kaczmarek L. (2007) TIMP-1 abolishes MMP-9-dependent long-lasting long-term potentiation in the prefrontal cortex. J. Biol. Psychiatry 62, 359362.
  • Papatheodoropoulos C. and Kostopoulos G. (2002) Spontaneous GABA(A)-dependent synchronous periodic activity in adult rat ventral hippocampal slices. Neurosci. Lett. 319, 1720.
  • Paxinos G. and Franklin K. B. J. (2001) The Mouse Brain in Stereotaxic Coordinates, Academic Press, San Diego.
  • Post A., Ackl N., Rücker M., Schreiber Y., Binder E. B., Ising M., Sonntag A., Holsboer F. and Almeida O. F. (2006) Toward a reliable distinction between patients with mild cognitive impairment and Alzheimer-type dementia versus major depression. Biol. Psychiatry 59, 858862.
  • Rose G. M. and Dunwiddie T. V. (1986) Induction of hippocampal long-term potentiation using physiologically patterned stimulation. Neurosci. Lett. 69, 244248.
  • Sennvik K., Fastbom J., Blomberg M., Wahlund L. O., Winblad B. and Benedikz E. (2000) Levels of alpha- and beta secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer’s disease patients. Neurosci. Lett. 278, 169172.
  • Sternlicht M. D. and Werb Z. (2001) How matrix metalloproteinases regulate cell behaviour. Annu. Rev. Cell Dev. Biol. 17, 463516.
  • Talamagas A. A., Efthimiopoulos S., Tsilibary E. C., Figueiredo-Pereira M. E. and Tzinia A. K. (2007) Abeta(1-40)-induced secretion of matrix metalloproteinase-9 results in sAPPalpha release by association with cell surface APP. Neurobiol. Dis. 28, 304315.
  • Taylor C. J., Ireland D. R., Ballagh I., Bourne K., Marechal N. M., Turner P. R., Bilkey D. K., Tate W. P. and Abraham W. C. (2008) Endogenous secreted amyloid precursor protein-alpha regulates hippocampal NMDA receptor function, long-term potentiation and spatial memory. Neurobiol. Dis. 31, 250260.
  • Turner P. R., O’Connor K., Tate W. P. and Abraham W. C. (2003) Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog. Neurobiol. 70, 132.
  • Wang X. B., Bozdagi O., Nikitczuk J. S., Zhai Z. W., Zhou Q. and Huntley G. W. (2008) Extracellular proteolysis by matrix metalloproteinase-9 drives dendritic spine enlargement and long-term potentiation coordinately. Proc. Natl. Acad. Sci. USA 105, 1952019525.
  • Wilczynski G. M., Konopacki F. A., Wilczek E. et al. (2008) Important role of matrix metalloproteinase 9 in epileptogenesis. J. Cell Biol. 180, 10211035.
  • Wright J. W. and Harding J. W. (2009) Contributions of matrix metalloproteinases to neural plasticity, habituation, associative learning and drug addiction. Neural Plast. 2009, 579382579394
  • Wright J. W., Brown T. E. and Harding J. W. (2007) Inhibition of hippocampal matrix metalloproteinase-3 and -9 disrupts spatial memory. Neural Plast. 2007, 7381373821
  • Yong V. W., Power C., Forsyth P. and Edwards D. R. (2001) Metalloproteinases in biology and pathology of the nervous system. Nat. Rev. Neurosci. 2, 502511.